Hydralazine Valproate for Cervical Cancer

NCT00532818 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

143

Enrollment

OTHER_GOV

Sponsor class

Conditions

Metastatic Cervical Cancer

Interventions

DRUG: Hydralazine and magnesium valproate
DRUG: Placebo

Sponsor

National Institute of Cancerología

Collaborators

[object Object]